• Regeneron Pharmaceuticals 2012 Annual Report Cover

Regeneron Pharmaceuticals 2012 Annual Report

A Breakthrough Year

The Regeneron Pharmaceuticals 2012 annual report communicates the importance of one of the most successful product launches in the history of the biopharmaceutical industry. This next-generation annual report also included a link to a video describing the life-changing experience of a patient receiving Regeneron’s EYLEA therapy. The chevron pattern hints at moving the company forward in a fast-paced but measured way.